The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Aligning Science Across Parkinson's, 2020Activation of Transposable Elements as a Trigger of Neuroinflammation in Parkinson’s Disease
Study Rationale:
Inflammation is a common event in Parkinson’s disease (PD), but its source remains unclear. There are many candidates that could cause inflammation in the nervous system. One likely... -
Aligning Science Across Parkinson's, 2020From Cancer Associations to Altered Immunity in the Pathogenesis of Parkinson’s Disease
Study Rationale:
Parkinson’s disease is characterized by premature death of dopamine-producing neurons in the brain; cancer is characterized by overgrowth of dividing cells. Despite being very... -
Aligning Science Across Parkinson's, 2020Adaptive Immunity in the Etiology and Progression of Parkinson’s Disease
Study Rationale:
Research from our team indicates that immune cells may play central roles in the development of Parkinson’s disease (PD). In PD, certain types of nerve cells can activate specific... -
Aligning Science Across Parkinson's, 2020Defining the Cellular and Molecular Determinants of Variable Genetic Penetrance in Parkinson’s Disease
Study Rationale:
Why do some people develop Parkinson’s disease (PD) while others do not? Although many genetic risk factors have been identified, we still cannot confidently answer this question, or... -
Aligning Science Across Parkinson's, 2020Cellular Mechanism of LRRK2 in Health and Disease
Study Rationale:
Leucine Rich Repeat Kinase 2 (LRRK2), is the most commonly mutated gene in inherited forms of Parkinson’s disease (PD). The LRRK2 gene codes for a protein kinase, an enzyme that adds... -
Aligning Science Across Parkinson's, 2020IMPACT-PD - Implications of Polyamine and Glucosylceramide Transport in Parkinson’s Disease
Study Rationale:
Mutations in the genes ATP13A2 (PARK9) and ATP10B trigger Parkinson’s disease (PD) and cause dysfunction of lysosomes, the recycling compartments of the cell. We explained these...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.